<DOC>
	<DOC>NCT01789723</DOC>
	<brief_summary>The purpose of this study is determine the optimal dose and schedule of Fusilev to prevent or reduce Mucositis in patients with Non-Hodgkin's Lymphoma receiving Folotyn treatment.</brief_summary>
	<brief_title>Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn</brief_title>
	<detailed_description>This is an open label, uncontrolled, nonrandomized, multicenter, dose finding, Phase 1 study primarily to determine the optimal dose and schedule of Fusilev to prevent or reduce Folotyn-related Grade 3 or higher oral Mucositis.</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Aminopterin</mesh_term>
	<criteria>At least 18 years of age Patients with relapsed or refractory NHL who are eligible for Folotyn treatment. Patient has histologically/cytologically confirmed, measurable (lesion or node ≥ 2 cm by computed tomography [CT] Progressive disease or persistent disease after at least 1 prior treatment ECOG performance status ≤ 2 Adequate hematological, hepatic, and renal function Active concurrent malignancy (except nonmelanoma skin cancer or carcinoma in situ of the cervix) Congestive heart failure Uncontrolled hypertension Known human immunodeficiency virus (HIV)positive diagnosis Active uncontrolled infection, underlying medical condition, or other serious illness that would impair the ability of the patient to receive protocol treatment Major surgery within 14 days of enrollment Pregnant or breastfeeding women Symptomatic central nervous system (CNS) metastases or lesions for which treatment is required. Patients who received prophylactic CNS treatment are eligible Previous exposure to pralatrexate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>